Guselkumab (GUS) in Psoriasis Patients With a History of Malignancy: 5-Year Safety From VOYAGE (VOY)1&2

Main Article Content

Andrew Blauvelt
Diamant Thaci
Kim Papp
Vincent Ho
Kamran Ghoreschi
Byung Soo Kim
Megan Miller
Yaung-Kaung Shen
Yin You
Jenny Yu
Ya-Wen Yang
Jeffrey Crowley
Peter Foley






1. Wong PKK, et al. Curr Rheumatol Rep. 2018;20:64.

2. Plachouri K-M, Georgiou S. Int J Dermatol. 2019;58:1008-13.

3. Reich K, et al. Br J Dermatol. 2021 Jun 9. doi: 10.1111/bjd.20568. Online ahead of print.

4. Reich K, et al. J Am Acad Dermatol. 2020;82:936-45.

Similar Articles

<< < 3 4 5 6 7 8 

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)

1 2 3 4 5 6 7 > >>